secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harvard Apparatus Regenerative Technology, Inc. (HRGN)
CIK:        0001563665
Form:       8-K
Filed at:   2022-02-03T23:59:59+00:00
Accession:  0001104659-22-011367
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Biostage posts webinar video; interim CEO outlines plans for clinical trial, capital raise, NASDAQ uplisting
--------------------------------------------------------------------------------

- Biostage posted video of January 27 webinars with founder/interim CEO David Green.
- Webinar covered plans for approved clinical trial, raising capital, and uplisting to NASDAQ.
- Video includes Q&A sessions from both webinars.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563665/000110465922011367/0001104659-22-011367-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563665/000110465922011367/tm225487d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-011367

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer